Zdrowie i gospodarka · 7.01.2011
FDA Transparency Initiative: Improving Transparency to Regulated Industry
As part of the third phase of the Transparency Initiative, the Food and Drug Administration (FDA) is announcing the availability of a report entitled "FDA Transparency Initiative: Improving Transparency to Regulated Industry." The report includes 19 action items and 5 draft proposals to improve transparency to regulated industry. FDA is seeking public comment on the content of the draft proposals, as well as on which draft proposals should be given priority.